Research graph
References from Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/nrc3744
10.1038/nrc3744 · External reference
10.1158/0008-5472.can-14-0155
10.1158/0008-5472.can-14-0155 · External reference
10.3322/caac.21332
10.3322/caac.21332 · External reference
10.1038/nrgastro.2017.33
10.1038/nrgastro.2017.33 · External reference
The recurring features of molecular subtypes in distinct gastrointestinal malignancies-A systematic review
10.1016/j.critrevonc.2021.103428 · 2021 · External reference
10.1634/theoncologist.2018-0143
10.1634/theoncologist.2018-0143 · External reference
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas
2018 · External reference
The tumor microenvironment
10.1016/j.cub.2020.06.081 · 2020 · External reference
Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Annals of Oncology: Official
2016 · External reference
10.1016/j.trecan.2020.02.022
10.1016/j.trecan.2020.02.022 · External reference
Biological role of matrix stiffness in tumor growth and treatment
10.1186/s12967-022-03768-y · 2022 · External reference
Multiscale modeling of solid stress and tumor cell invasion in response to dynamic mechanical microenvironment
10.1007/s10237-019-01231-4 · 2020 · External reference
10.1126/science.1176009
10.1126/science.1176009 · External reference
10.1111/febs.15282
10.1111/febs.15282 · External reference
10.1002/jcb.27681
10.1002/jcb.27681 · External reference
Matrix Stiffness Contributes to Cancer Progression by Regulating Transcription Factors
10.3390/cancers14041049 · 2022 · External reference
10.1016/j.bbcan.2021.188583
10.1016/j.bbcan.2021.188583 · External reference
Matrix stiffness and colorectal cancer
10.2147/ott.s231010 · 2020 · External reference
ECM-receptor regulatory network and its prognostic role in colorectal cancer
10.3389/fgene.2021.782699 · 2021 · External reference
Development and validation of an ECM-related prognostic signature to predict the immune landscape of human hepatocellular carcinoma
10.1186/s12885-022-10049-w · 2022 · External reference
Zinc Finger Protein CTCF Regulates Extracellular Matrix (ECM)-Related Gene Expression Associated With the Wnt Signaling Pathway in Gastric Cancer
10.3389/fonc.2020.625633 · 2020 · External reference
Reduction of Liver Metastasis Stiffness Improves Response to Bevacizumab in Metastatic Colorectal Cancer
10.1016/j.ccell.2020.05.005 · 2020 · External reference
Conserved pan-cancer microenvironment subtypes predict response to immunotherapy
10.1016/j.ccell.2021.04.014 · 2021 · External reference
10.1038/ng.3398
10.1038/ng.3398 · External reference
10.1016/j.cell.2015.05.044
10.1016/j.cell.2015.05.044 · External reference
10.1038/s41467-018-06654-8
10.1038/s41467-018-06654-8 · External reference
Identification of gastric cancer subtypes based on pathway clustering. NPJ Precision
2021 · External reference
10.1186/s13059-017-1349-1
10.1186/s13059-017-1349-1 · External reference
Simultaneous enumeration of cancer and immune cell types from bulk tumor gene expression data
10.7554/elife.26476 · 2017 · External reference
Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation
10.1016/j.cell.2018.03.034 · 2018 · External reference
GSVA: gene set variation analysis for microarray and RNA-seq data
10.1186/1471-2105-14-7 · 2013 · External reference
10.1038/s41568-020-0290-x
10.1038/s41568-020-0290-x · External reference
10.1038/nmeth.3853
10.1038/nmeth.3853 · External reference
oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data
10.1093/bib/bbab260 · 2021 · External reference
Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
2022 · External reference
10.1016/j.semcancer.2019.08.004
10.1016/j.semcancer.2019.08.004 · External reference
Epithelial to mesenchymal transition: key regulator of pancreatic ductal adenocarcinoma progression and chemoresistance
10.3390/cancers13215532 · 2021 · External reference
10.3174/ajnr.a5415
10.3174/ajnr.a5415 · External reference
10.1186/s12943-017-0600-4
10.1186/s12943-017-0600-4 · External reference
10.1136/gutjnl-2015-309304
10.1136/gutjnl-2015-309304 · External reference
10.1053/j.gastro.2017.11.280
10.1053/j.gastro.2017.11.280 · External reference
10.1146/annurev-pathol-052016-100322
10.1146/annurev-pathol-052016-100322 · External reference
10.1038/nature25492
10.1038/nature25492 · External reference
10.1038/nri3902
10.1038/nri3902 · External reference
10.1038/onc.2016.57
10.1038/onc.2016.57 · External reference
10.1242/jcs.180539
10.1242/jcs.180539 · External reference
Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors
10.1172/jci45817 · 2012 · External reference
10.1158/0008-5472.can-18-0601
10.1158/0008-5472.can-18-0601 · External reference
10.1126/scisignal.2005189
10.1126/scisignal.2005189 · External reference
10.1158/1078-0432.ccr-18-0329
10.1158/1078-0432.ccr-18-0329 · External reference
10.1038/ncomms5619
10.1038/ncomms5619 · External reference
10.18632/oncotarget.8515
10.18632/oncotarget.8515 · External reference
10.18632/aging.202449
10.18632/aging.202449 · External reference
Microenvironment rigidity modulates responses to the HER2 receptor tyrosine kinase inhibitor lapatinib via YAP and TAZ transcription factors
10.1091/mbc.e15-07-0456 · 2015 · External reference
Cirrhotic stiffness affects the migration of hepatocellular carcinoma cells and induces sorafenib resistance through YAP
10.1002/jcp.27078 · 2019 · External reference
Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells
10.1038/oncsis.2017.54 · 2017 · External reference
10.3892/ijo.2017.3877
10.3892/ijo.2017.3877 · External reference
MiRNA-mediated EMT and CSCs in cancer chemoresistance
10.1186/s40164-021-00206-5 · 2021 · External reference
10.1016/j.trecan.2016.11.008
10.1016/j.trecan.2016.11.008 · External reference
10.1038/s41568-019-0238-1
10.1038/s41568-019-0238-1 · External reference
